Mucormycosis in Iran: A six-year retrospective experience

被引:52
作者
Dolatabadi, S. [1 ]
Ahmadi, B. [2 ]
Rezaei-Matehkolaei, A. [3 ]
Zarrinfar, H. [4 ]
Skiada, A. [5 ]
Mirhendi, H. [6 ]
Nashibi, R. [7 ]
Niknejad, F. [8 ]
Nazeri, M. [9 ]
Rafiei, A. [3 ]
Gharaghani, M. [10 ]
Erami, M. [11 ]
Taghipour, S. [12 ]
Piri, F. [3 ]
Makimura, K. [13 ]
机构
[1] Sabzevar Univ New Technol, Fac Engn, Sabzevar, Iran
[2] Bushehr Univ Med Sci, Sch Para Med, Dept Med Lab Sci, Bushehr, Iran
[3] Ahvaz Jundishapu Univ Med, Infect & Trop Dis Res Ctr, Sch Med, Hlth Res Inst,Dept Med Mycol, Ahvaz, Iran
[4] Mashhad Univ Med Sci, Allergy Res Ctr, Mashhad, Iran
[5] Natl & Kapodistrian Univ Athens, Laiko Hosp, Athens, Greece
[6] Isfahan Univ Med Sci, Sch Med, Dept Med Parasitol & Mycol, Esfahan, Iran
[7] Ahvaz Jundishapur Univ Med Sci, Razi Teaching Hosp, Infect & Trop Dis Res Ctr, Hlth Res Inst,Infect Dis Dept, Ahvaz, Iran
[8] Golestan Univ Med Sci, Lab Sci Res Ctr, Gorgan, Iran
[9] Kashan Univ Med Sci, Fac Med, Dept Med Parasitol & Mycol, Kashan, Iran
[10] Yasuj Univ Med Sci, Cellular & Mol Res Ctr, Yasuj, Iran
[11] Kashan Univ Med Sci, Shahid Beheshti Hosp, Kashan, Iran
[12] Shahrekord Univ Med Sci, Fac Med, Dept Med Parasitol & Mycol, Shahrekord, Iran
[13] Teikyo Univ, Div Clin Lab Med, Lab Space & Environm Med, Grad Sch Med Care & Technol,Grad Sch Med, Tokyo, Japan
来源
JOURNAL DE MYCOLOGIE MEDICALE | 2018年 / 28卷 / 02期
关键词
Mucormycosis; Diabetes mellitus; Rhizopus arrhizus; ANTIFUNGAL SUSCEPTIBILITY; FUNGAL-INFECTIONS; EPIDEMIOLOGY; DIAGNOSIS; ZYGOMYCOSIS; GUIDELINES; FRANCE;
D O I
10.1016/j.mycmed.2018.02.014
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mucormycosis is a devastating infection caused by Mucoralean fungi (Mucormycotina, Mucorales). Data concerning the global epidemiology of mucormycosis are scarce and little is known about the characteristics of mucormycosis in Iran. In this study, we aimed to understand the distribution of this infection in Iran retrospectively and to ascertain whether the patterns of infection are associated with specific host factors or not. A total of 208 cases were included in this study occurring during 2008-2014 and were validated according to (EORTC/MSG) criteria. A rising trend as significant increase from 9.7% in 2008 to 23.7% in 2014 was observed. The majority of patients were female (51.4%) with median age of 50 and the infections were seen mostly in autumn season (39.4%). Diabetes mellitus (75.4%) was the most common underlying condition and sinus involvement (86%) was the mostly affected site of infection. Amphotericin B (AmB) was the drug of choice for the majority of cases. Sixty four isolates did not show any growth in the lab and only 21 cases were evaluated by ITS sequencing, among them; Rhizopus arrhizus var. arrhizus was the dominant species. Considering the high mortality rate of mucormycosis, early and accurate diagnosis, with the aid of molecular methods may provide accurate treatments and improve the survival rate. Therefore, increased monitoring and awareness of this life-threatening disease is critical. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:269 / 273
页数:5
相关论文
共 43 条
[11]   Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group [J].
De Pauw, Ben ;
Walsh, Thomas J. ;
Donnelly, J. Peter ;
Stevens, David A. ;
Edwards, John E. ;
Calandra, Thierry ;
Pappas, Peter G. ;
Maertens, Johan ;
Lortholary, Olivier ;
Kauffman, Carol A. ;
Denning, David W. ;
Patterson, Thomas F. ;
Maschmeyer, Georg ;
Bille, Jacques ;
Dismukes, William E. ;
Herbrecht, Raoul ;
Hope, William W. ;
Kibbler, Christopher C. ;
Kullberg, Bart Jan ;
Marr, Kieren A. ;
Munoz, Patricia ;
Odds, Frank C. ;
Perfect, John R. ;
Restrepo, Angela ;
Ruhnke, Markus ;
Segal, Brahm H. ;
Sobel, Jack D. ;
Sorrell, Tania C. ;
Viscoli, Claudio ;
Wingard, John R. ;
Zaoutis, Theoklis ;
Bennett, John E. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (12) :1813-1821
[12]  
Dolatabadi S., 2015, MUCORALES FOOD INFEC
[13]   Diversity and delimitation of Rhizopus microsporus [J].
Dolatabadi, Somayeh ;
Walther, Grit ;
van den Ende, A. H. G. Gerrits ;
de Hoog, G. S. .
FUNGAL DIVERSITY, 2014, 64 (01) :145-163
[14]  
El-Herte RI, 2012, Adv Infect Dis, V2, P76, DOI [10.4236/aid.2012.23012, DOI 10.4236/AID.2012.23012]
[15]   Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005-2011 [J].
Esteghamati, Alireza ;
Etemad, Koorosh ;
Koohpayehzadeh, Jalil ;
Abbasi, Mehrshad ;
Meysamie, Alipasha ;
Noshad, Sina ;
Asgari, Fereshteh ;
Mousavizadeh, Mostafa ;
Rafei, Ali ;
Khajeh, Elias ;
Neishaboury, Mohamadreza ;
Sheikhbahaei, Sara ;
Nakhjavani, Manouchehr .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 (02) :319-327
[16]   Pathogenesis of Mucormycosis [J].
Ibrahim, Ashraf S. ;
Spellberg, Brad ;
Walsh, Thomas J. ;
Kontoyiannis, Dimitrios P. .
CLINICAL INFECTIOUS DISEASES, 2012, 54 :S16-S22
[17]   Mucormycosis: a 10-year experience at a tertiary care center in Turkey [J].
Komur, Suheyla ;
Inal, Ayse Seza ;
Kurtaran, Behice ;
Ulu, Aslihan ;
Uguz, Aysun ;
Aksu, Hasan Salih Zeki ;
Tasova, Yesim .
TURKISH JOURNAL OF MEDICAL SCIENCES, 2016, 46 (01) :58-62
[18]   Prospective antifungal therapy (PATH) alliance®: focus on mucormycosis [J].
Kontoyiannis, Dimitrios P. ;
Azie, Nkechi ;
Franks, Billy ;
Horn, David L. .
MYCOSES, 2014, 57 (04) :240-246
[19]   Future Directions in Mucormycosis Research [J].
Kontoyiannis, Dimitrios P. ;
Lewis, Russell E. ;
Lotholary, Oliver ;
Spellberg, Brad ;
Petrikkos, Georgios ;
Roillides, Emmanuel ;
Ibrahim, Ashraf ;
Walsh, Thomas J. .
CLINICAL INFECTIOUS DISEASES, 2012, 54 :S79-S85
[20]   Evaluation of 28 cases of mucormycosis [J].
Kursun, Ebru ;
Turunc, Tuba ;
Demiroglu, Yusuf Ziya ;
Aliskan, Hikmet Eda ;
Arslan, Ayse Hande .
MYCOSES, 2015, 58 (02) :82-87